2C
CDMO

272 Capital’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

272 Capital’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-264,540
Closed -$1.89M – 82
2024
Q2 		$1.89M Sell
264,540
-545,453
-67% -$4.17M 0.95% 39
2024
Q1 		$5.43M Buy
809,993
+230,000
+40% +$1.58M 2.17% 17
2023
Q4 		$3.95M Buy
579,993
+469,291
+424% +$3.02M 1.33% 24
2023
Q3 		$1.05M Buy
110,702
+37,721
+52% +$454K 0.42% 44
2023
Q2 		$1.02M Buy
+72,981
New +$1.24M 0.37% 46

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

272 Capital's CDMO Position: Q3 2024 in Review

272 Capital sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2024, closing a stake of 264,540 shares — an estimated $1.89M sold.

272 Capital first reported a position in CDMO in Q2 2023 and held it in 5 quarters. The position peaked at $5.43M in Q1 2024. 171 funds tracked by Wall St. Rank hold CDMO as of Q3 2024.

  • 272 Capital reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • 272 Capital sold 264,540 Avid Bioservices, Inc. Common Stock shares in Q3 2024, an estimated $1.89M.
  • 272 Capital first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2023 and held it in 5 quarters.
  • 272 Capital's Avid Bioservices, Inc. Common Stock position peaked at $5.43M in Q1 2024.
  • 171 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2024.

Based on 272 Capital's 13F filing for Q3 2024, filed 14 Nov 2024.